Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes

British Journal of Dermatology

Volumn 149, Issue 3, 2003, Pages 484-491

  Mork G ^a   Schjerven, H ^a   Mangschau, L ^a   Soyland E ^a   Brandtzaeg, P ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Calprotectin; Cytokines; Human keratinocytes; L1 protein; MRP 14; MRP 8; Skin disease

Indexed keywords

CALGRANULIN; CALPROTECTIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADHERENT CELL; ADULT; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; KERATINOCYTE; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; CELLS, CULTURED; CYTOKINES; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; KERATINOCYTES; LEUKOCYTE L1 ANTIGEN COMPLEX; RNA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0142061056     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05536.x     Document Type: Article

References (34)

1. Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134: 1-6.
2. Dale I, Brandtzaeg P, Fagerhol MK et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leucocytes. Am J Clin Pathol 1985; 84: 24-34.
3. Johne B, Fagerhol MK, Lyberg T et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Clin Pathol Mol Pathol 1997; 50: 113-23.
4. Kligman D, Hilt DC. The S100 protein family. Trends Biochem Sci 1988; 13: 437-43.
5. Teigelkamp S, Bhardwaj RS, Roth J et al. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J Biol Chem 1991; 266: 13462-7.
6. Brandtzaeg P, Dale I, Gabrielsen TØ. The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology 1992; 21: 191-6.
7. Steinbakk M, Naess-Andersen C-F, Lingaas E et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990; 336: 763-5.
8. Sohnle PG, Hahn BL, Santhanagopalan V. Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms. J Infect Dis 1996; 174: 1369-72.
9. Sugarman B. Zinc and infections. Rev Infect Dis 1983; 5: 137-47.
10. Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun 2001; 6: 3692-6.
11. Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect Immun 2001; 7: 4242-7.
12. Yui S, Mikami M, Tsurumaki K et al. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J Leukoc Biol 1997; 61: 50-7.
13. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol 1987; 87: 700-7.
14. Ross KF, Herzberg MC. Calprotectin expression by gingival epithelial cells. Infect Immun 2001; 69: 3248-54.
15. Gabrielsen TØ, Dale I, Brandtzaeg P. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. J Am Acad Dermatol 1986; 15: 173-9.
16. Kelly SE, Jones DB, Fleming S. Calgranulin expression in inflammatory dermatoses. J Pathol 1989; 159: 17-21.
17. Brandtzaeg P, Jones DB, Flavell DJ, Fagerhol MK. Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. J Clin Pathol 1988; 41: 963-70.
18. Parks DR, Bryan VM, Oi VT, Hertzenberg LA. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci USA 1979; 76: 1962-6.
19. Kvale D, Krajci P, Brandtzaeg P. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol 1992; 35: 669-76.
20. Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodological study. Scand J Gastroenterol 1992; 27: 793-8.
21. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology (Krawetz S. Misener S. eds). Totowa, NJ: Humana Press, 2000; 132: 365-86. (Code available at http://www-genome.wi.mit.edu/genome_software/other/primer3.html.).
22. Jahnsen FL, Haye R, Gran E et al. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. J Immunol 1999; 163: 1545-51.
23. McNamara MP, Weissner JH, Collins-Lech C et al. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet 1988; ii: 1163-5.
24. Santhanagopalan V, Hahn BL, Sohnle PG. Resistance of zinc-supplemented Candida albicans cells to the growth inhibitory effect of calprotectin. J Infect Dis 1995; 171: 1289-94.
25. Thestrup-Pedersen K. Cytokines and skin diseases. Nord Med 1995; 110: 79-81.
26. Sander J, Fagerhol MK, Bakken JS et al. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357-62.
27. Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol 1997; 36: 191-6.
28. Teunissen MB, Koomen CW, de Waal Malefyt R et al. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998; 111: 645-91.
29. Fujisawa H, Nakayama K, Nomura T et al. Interleukin-1 and lipopolysaccharide enhance intercellular adhesion molecule-1 expression in cell lines of human squamous cell carcinoma. J Dermatol Sci 1997; 14: 109-14.
30. Li J, Farthing PM, Thornhill MH. Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor-α and interferon-γ. J Oral Pathol Med 2000; 29: 438-44.
31. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leucocyte-derived protein (L1). Scand J Haematol 1980; 24: 393-8.
32. Larsson L-I. Immunocytochemistry of living cells. In: Immunocytochemistry: Theory and Practice (Larsson L-I. ed.). Boca Raton, FL: CRC Press. 1988: 185-7.
33. Gabrielsen TØ, Brandtzaeg P, Berntzen HB et al. Quantitation of calprotectin (the leukocyte protein L1) in plasma from patients with various skin disorders. Eur J Dermatol 1992; 2: 189-93.
34. Nilsen EM, Johansen FE, Kvale D et al. Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes. Eur J Immunol 1999; 29: 168-79.